FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jun. 1, 2015--
MEDNAX, Inc. (NYSE:MD), today announced that it is scheduled to make a
presentation on Wednesday, June 10, 2015 at 2:40 p.m. CDT to investors
attending the William Blair 35th Annual Growth Stock Conference in
The presentation will be broadcast through a live audio webcast and will
be available for replay at www.mednax.com/investors.
MEDNAX, Inc. is a national medical group comprised of the nation's
leading providers of neonatal, anesthesia, maternal-fetal and pediatric
physician subspecialty services. Physicians and advanced practitioners
practicing as part of MEDNAX are reshaping the delivery of care within
their specialties and subspecialties, using evidence-based tools,
continuous quality initiatives and clinical research to enhance patient
outcomes and provide high-quality, cost-effective care. Pediatrix
Medical Group, a division of MEDNAX, was founded in 1979 and includes
neonatal physicians who provide services at more than 370 neonatal
intensive care units, and collaborate with affiliated maternal-fetal
medicine, pediatric cardiology, pediatric critical care and other
physician subspecialists to provide a clinical care continuum. Pediatrix
is also the nation's largest provider of newborn hearing screens.
American Anesthesiology, a division of MEDNAX, was established in 2007
and includes more than 2,400 anesthesiologists and advanced
practitioners who provide anesthesia care to patients in connection with
surgical and other procedures as well as pain management. MEDNAX,
through its affiliated professional corporations, employs more than
2,675 physicians in 34 states and Puerto Rico. In addition to its
national physician network, MEDNAX provides services to medical
providers in over 40 states through two complementary businesses,
consisting of a revenue cycle management company and a consulting
services company. Additional information is available at www.mednax.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150601005307/en/
Source: MEDNAX, Inc.
Charles Lynch, 954-384-0175, x 5692
President, Strategy and Investor Relations